N-acetylsphingosine

N-acetylsphingosine is a lipid of Sphingolipids (SP) class. N-acetylsphingosine is associated with abnormalities such as Morphologically altered structure, Atherosclerosis, Cardiovascular Diseases, Hyperinsulinism and Gigantism. The involved functions are known as inhibitors, anti-apoptosis, Apoptosis, Dephosphorylation and immunoreactivity. N-acetylsphingosine often locates in Plasma membrane, Mitochondria, Pore, Membrane and Cytoplasmic matrix. The associated genes with N-acetylsphingosine are EGR3 gene, CFB gene, FATE1 gene, P4HTM gene and PFDN4 gene. The related lipids are Sphingolipids, Cardiolipins, Glycerophospholipids, dihydroceramide and Phosphatidic Acid.

Cross Reference

Introduction

To understand associated biological information of N-acetylsphingosine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with N-acetylsphingosine?

N-acetylsphingosine is suspected in Morphologically altered structure, protrusion, DERMATITIS HERPETIFORMIS, FAMILIAL, Atherosclerosis, Cardiovascular Diseases, Hyperinsulinism and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with N-acetylsphingosine

MeSH term MeSH ID Detail
Lung Neoplasms D008175 171 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Melanoma D008545 69 associated lipids
Glioma D005910 112 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Arteriosclerosis D001161 86 associated lipids
Leukemia D007938 74 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Per page 10 20 50 | Total 26

PubChem Associated disorders and diseases

What pathways are associated with N-acetylsphingosine

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with N-acetylsphingosine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with N-acetylsphingosine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with N-acetylsphingosine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with N-acetylsphingosine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with N-acetylsphingosine?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with N-acetylsphingosine

Download all related citations
Per page 10 20 50 100 | Total 506
Authors Title Published Journal PubMed Link
pmid:
Perks CM et al. Activation of integrin and ceramide signalling pathways can inhibit the mitogenic effect of insulin-like growth factor I (IGF-I) in human breast cancer cell lines. 1999 Br. J. Cancer pmid:10070857
Shinpo K et al. Protective effects of the TNF-ceramide pathway against glutamate neurotoxicity on cultured mesencephalic neurons. 1999 Brain Res. pmid:10082875
Medvedev AE et al. Limited role of ceramide in lipopolysaccharide-mediated mitogen-activated protein kinase activation, transcription factor induction, and cytokine release. 1999 J. Biol. Chem. pmid:10092612
Mahajan S et al. Rational design and synthesis of a novel anti-leukemic agent targeting Bruton's tyrosine kinase (BTK), LFM-A13 [alpha-cyano-beta-hydroxy-beta-methyl-N-(2, 5-dibromophenyl)propenamide]. 1999 J. Biol. Chem. pmid:10092645
MacPhee I and Barker PA Extended ceramide exposure activates the trkA receptor by increasing receptor homodimer formation. 1999 J. Neurochem. pmid:10098845
Blázquez C et al. The stimulation of ketogenesis by cannabinoids in cultured astrocytes defines carnitine palmitoyltransferase I as a new ceramide-activated enzyme. 1999 J. Neurochem. pmid:10098887
Kovács P et al. Effect of C2 ceramide on the inositol phospholipid metabolism (uptake of 32P, 3H-serine and 3H-palmitic acid) and apoptosis-related morphological changes in Tetrahymena. 1999 Comp. Biochem. Physiol. C, Pharmacol. Toxicol. Endocrinol. pmid:10190048
Puranam KL et al. CLN3 defines a novel antiapoptotic pathway operative in neurodegeneration and mediated by ceramide. 1999 Mol. Genet. Metab. pmid:10191118
Su X et al. Differential activation of phosphoinositide 3-kinase by endothelin and ceramide in colonic smooth muscle cells. 1999 Am. J. Physiol. pmid:10198327
Tolleson WH et al. Fumonisin B1 induces apoptosis in cultured human keratinocytes through sphinganine accumulation and ceramide depletion. 1999 Int. J. Oncol. pmid:10200332
Alesse E et al. The growth arrest and downregulation of c-myc transcription induced by ceramide are related events dependent on p21 induction, Rb underphosphorylation and E2F sequestering. 1998 Cell Death Differ. pmid:10200487
Lee BR and Um HD Hydrogen peroxide suppresses U937 cell death by two different mechanisms depending on its concentration. 1999 Exp. Cell Res. pmid:10222135
Herr I et al. FK506 prevents stroke-induced generation of ceramide and apoptosis signaling. 1999 Brain Res. pmid:10224298
Watton SJ and Downward J Akt/PKB localisation and 3' phosphoinositide generation at sites of epithelial cell-matrix and cell-cell interaction. 1999 Curr. Biol. pmid:10226029
Mengubas K et al. Ceramide-induced killing of normal and malignant human lymphocytes is by a non-apoptotic mechanism. 1999 Oncogene pmid:10229201
Kim YH and Kim SS Increase of MnSOD expression and decrease of JNK activity determine the TNF sensitivity in bcl2-transfected L929 cells. 1999 Cytokine pmid:10328866
Mengubas K et al. Killing of T lymphocytes by synthetic ceramide is by a nonapoptotic mechanism and is abrogated following mitogenic activation. 1999 Exp. Cell Res. pmid:10328959
Taniwaki T et al. Ceramide induces apoptosis to immature cerebellar granule cells in culture. 1999 Neurochem. Res. pmid:10344598
Masamune A et al. Helicobacter pylori-dependent ceramide production may mediate increased interleukin 8 expression in human gastric cancer cell lines. 1999 Gastroenterology pmid:10348816
Pruschy M et al. Ceramide triggers p53-dependent apoptosis in genetically defined fibrosarcoma tumour cells. 1999 Br. J. Cancer pmid:10360645
Hisano N et al. Induction and suppression of endothelial cell apoptosis by sphingolipids: a possible in vitro model for cell-cell interactions between platelets and endothelial cells. 1999 Blood pmid:10361127
Li PL et al. Effect of ceramide on KCa channel activity and vascular tone in coronary arteries. 1999 Hypertension pmid:10373230
Stewart CE et al. Increased, not decreased activation of the insulin-like growth factor (IGF) receptor signalling pathway during ceramide-induced apoptosis. 1999 Growth Horm. IGF Res. pmid:10373346
Jones BE et al. Ceramide induces caspase-independent apoptosis in rat hepatocytes sensitized by inhibition of RNA synthesis. 1999 Hepatology pmid:10385659
Dallalio G et al. Inhibition of human erythroid colony formation by ceramide. 1999 Exp. Hematol. pmid:10390188
Shinoda J et al. Effect of ceramide on interleukin-6 synthesis in osteoblast-like cells. 1999 Cell. Signal. pmid:10400316
Buisson-Legendre N et al. Involvement of the 92-kDa gelatinase (matrix metalloproteinase-9) in the ceramide-mediated inhibition of human keratinocyte growth. 1999 Biochem. Biophys. Res. Commun. pmid:10403818
Brindley DN et al. Tumor necrosis factor-alpha and ceramides in insulin resistance. 1999 Lipids pmid:10419100
Pahan K et al. Induction of the manganese superoxide dismutase gene by sphingomyelinase and ceramide. 1999 J. Neurochem. pmid:10428046
Yoshimura S et al. Inhibition of neutral sphingomyelinase activation and ceramide formation by glutathione in hypoxic PC12 cell death. 1999 J. Neurochem. pmid:10428064
Scaffidi C et al. Differential modulation of apoptosis sensitivity in CD95 type I and type II cells. 1999 J. Biol. Chem. pmid:10428830
Woessmann W et al. An essential role for mitogen-activated protein kinases, ERKs, in preventing heat-induced cell death. 1999 J. Cell. Biochem. pmid:10440934
Maile LA et al. The role of cell surface attachment and proteolysis in the insulin-like growth factor (IGF)-independent effects of IGF-binding protein-3 on apoptosis in breast epithelial cells. 1999 Endocrinology pmid:10465274
Belaud-Rotureau MA et al. Ceramide-induced apoptosis occurs independently of caspases and is decreased by leupeptin. 1999 Cell Death Differ. pmid:10467353
Askew DJ et al. Characterization of Apt- cell lines exhibiting cross-resistance to glucocorticoid- and Fas-mediated apoptosis. 1999 Cell Death Differ. pmid:10467354
Pirianov G et al. Potentiation by vitamin D analogs of TNFalpha and ceramide-induced apoptosis in MCF-7 cells is associated with activation of cytosolic phospholipase A2. 1999 Cell Death Differ. pmid:10510471
Meroni SB et al. Effect of N-acetylsphingosine (C2) and the ceramidase inhibitor (1S,2R)-D-erythro-2-(N-myristoylamino)-1-phenyl-1-propanol on the regulation of Sertoli cell function. 1999 Sep-Oct J. Androl. pmid:10520574
Olivera A et al. Sphingosine kinase expression increases intracellular sphingosine-1-phosphate and promotes cell growth and survival. 1999 J. Cell Biol. pmid:10545499
Park BJ et al. Effect of ceramide on apoptosis and phospholipase D activity in FRTL-5 thyroid cells. 1999 Exp. Mol. Med. pmid:10551263
De Jonghe S et al. Synthesis and apoptogenic activity of fluorinated ceramide and dihydroceramide analogues. 1999 Bioorg. Med. Chem. Lett. pmid:10560744
Shayman JA and Abe A 1-O-acylceramide synthase. 2000 Meth. Enzymol. pmid:10563315
Ruiz L et al. Delta9-tetrahydrocannabinol induces apoptosis in human prostate PC-3 cells via a receptor-independent mechanism. 1999 FEBS Lett. pmid:10570948
Zhang QH et al. Redistribution of cytochrome c is not an essential requirement in C2-ceramide induced apoptosis in HL-60 cells. 1999 Life Sci. pmid:10573189
Fujikawa K et al. Role of PI 3-kinase in angiopoietin-1-mediated migration and attachment-dependent survival of endothelial cells. 1999 Exp. Cell Res. pmid:10585289
Ito A et al. Possible involvement of cytochrome c release and sequential activation of caspases in ceramide-induced apoptosis in SK-N-MC cells. 1999 Biochim. Biophys. Acta pmid:10590315
Ogura M and Handa S Induction of apoptosis by novel synthesized acylamides of human lymphocytes. 2000 Biochim. Biophys. Acta pmid:10601700
Susen K et al. Nerve growth factor stimulates MAPK via the low affinity receptor p75(LNTR). 1999 FEBS Lett. pmid:10606727
Schürmann A et al. p21-activated kinase 1 phosphorylates the death agonist bad and protects cells from apoptosis. 2000 Mol. Cell. Biol. pmid:10611223
Abend M et al. Indications for an active process underlying spontaneous and radiation-induced micronucleation in L929 cells. 1999 Int. J. Radiat. Biol. pmid:10622263